Close Menu

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues were up 23 percent year over year on an adjusted basis.

The company's total revenues for the three months ended Sept. 30 were $101.3 million, compared with Q3 2017 revenues of $82.2 million adjusted for the change to ASC 606 accounting standards that the company adopted this January, and reported revenues of $83.8 million. Wall Street analysts had expected revenues of $94.4 million for the third quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.